Literature DB >> 7315850

Ehlers-Danlos syndrome with abnormal collagen fibrils, sinus of Valsalva aneurysms, myocardial infarction, panacinar emphysema and cerebral heterotopias.

L N Cupo, R E Pyeritz, J L Olson, S J McPhee, G M Hutchins, V A McKusick.   

Abstract

A 30 year old woman with marked joint hypermobility had severe, progressive lung disease, seizures, aneurysms of the sinuses of Valsalva and myocardial infarction documented during life. She died of intractable ventricular fibrillation, and postmortem examination showed myocardial injury in the distribution of the left coronary artery but no occlusive coronary artery disease. Severe panacinar emphysema was found in the lungs. Cerebral heterotopias with peculiar vascularization were present and were a likely cause of the seizure disorder. Electron microscopy showed dermal collagen fibrils to be heterogeneous in size, reduced in number, and irregular and frayed in appearance. This patient had a form of the Ehlers-Danlos syndrome, different from the 10 distinct variants described thus far, associated with lethal internal manifestations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7315850     DOI: 10.1016/0002-9343(81)90341-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis.

Authors:  Sorachai Srisuma; Soumyaroop Bhattacharya; Dawn M Simon; Siva K Solleti; Shivraj Tyagi; Barry Starcher; Thomas J Mariani
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

Review 2.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  The role of postmortem study in the diagnosis of the cause of death in a young man: a rare case of Ehlers-Danlos syndrome type IV.

Authors:  Natalia Escribano; Ileana Medina; Luis Ortega; M José Jiménez; M Concepción Millana; Roberto Fernández; Paloma Aragoncillo; Juliana Fariña
Journal:  BMJ Case Rep       Date:  2010-03-26

4.  Ehlers-Danlos syndrome and periventricular nodular heterotopia in a Spanish family with a single FLNA mutation.

Authors:  P Gómez-Garre; M Seijo; E Gutiérrez-Delicado; M Castro del Río; C de la Torre; C Gómez-Abad; J Morales-Corraliza; M Puig; J M Serratosa
Journal:  J Med Genet       Date:  2005-07-01       Impact factor: 6.318

5.  Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias.

Authors:  Manuel F Casanova
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

6.  Genotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers-Danlos syndrome type VI.

Authors:  P P Dembure; J H Priest; S C Snoddy; L J Elsas
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

7.  Computed tomography in patients with Ehlers-Danlos syndrome.

Authors:  H Hagino; I Eda; S Takashima; K Takeshita; A Sugitani
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

Review 8.  Extracellular matrix in lung development, homeostasis and disease.

Authors:  Yong Zhou; Jeffrey C Horowitz; Alexandra Naba; Namasivayam Ambalavanan; Kamran Atabai; Jenna Balestrini; Peter B Bitterman; Richard A Corley; Bi-Sen Ding; Adam J Engler; Kirk C Hansen; James S Hagood; Farrah Kheradmand; Qing S Lin; Enid Neptune; Laura Niklason; Luis A Ortiz; William C Parks; Daniel J Tschumperlin; Eric S White; Harold A Chapman; Victor J Thannickal
Journal:  Matrix Biol       Date:  2018-03-08       Impact factor: 11.583

Review 9.  Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

10.  Ehlers-Danlos syndrome, clotting disorders and muscular dystrophy.

Authors:  P Bertin; R Treves; A Julia; S Gaillard; R Desproges-Gotteron
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.